|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the CRXL 20-F filed Apr 22, 2009. Gene therapy The primary function of PER.C6 technology in the field of gene therapy is the production of adenoviral vectors a gene delivery mechanism based on a common cold virus that carries therapeutic genes and facilitates the delivery of the gene into the cells. Since the PER.C6 technology is the only available cell line that does not allow any formation of classical replication competent adenoviruses during the production of replication deficient vectors, the cell line may be applied across the entire adenovirus gene therapy field.
This excerpt taken from the CRXL 20-F filed May 7, 2008. Gene therapy The primary function of PER.C6 technology in the field of gene therapy is the production of adenoviral vectors—a gene delivery mechanism based on a common human virus—that carries therapeutic genes and facilitates the delivery of the gene into the cells. Since the PER.C6 technology is the only available cell line that does not allow any formation of classical replication competent adenoviruses during the production of replication deficient vectors, the cell line may be applied across the entire adenovirus gene therapy field.
This excerpt taken from the CRXL 20-F filed Jun 13, 2007. Gene therapy. The primary function of PER.C6 technology in the field of
gene therapy is the production of adenoviral vectors—a gene delivery mechanism
based on a common human virus—that carries therapeutic genes and facilitates
the delivery of the gene into the cells. Since the PER.C6 cell line is the only
available cell line that does not allow any formation of classical replication
competent adenoviruses during the production of replication deficient vectors,
the cell line may be applied across the entire adenovirus gene therapy field.
This excerpt taken from the CRXL 20-F filed Jul 6, 2006. Gene therapy. The
primary function of PER.C6 technology in the field of gene therapy is the
production of adenoviral vectors—a gene delivery mechanism based on a common
human virus—that carries therapeutic genes and facilitates the delivery of the
gene into the cells. Since the PER.C6 cell line is the only available cell line
that does not allow any formation of classical replication competent
adenoviruses during the production of replication deficient vectors, the cell
line may be applied across the entire adenovirus gene therapy field.
This excerpt taken from the CRXL 20-F filed Jun 29, 2006. Gene therapy. The
primary function of PER.C6 technology in the field of gene therapy is the
production of adenoviral vectors—a gene delivery mechanism based on a common
human virus—that carries therapeutic genes and facilitates the delivery of the
gene into the cells. Since the PER.C6 cell line is the only available cell line
that does not allow any formation of classical replication competent
adenoviruses during the production of replication deficient vectors, the cell
line may be applied across the entire adenovirus gene therapy field.
This excerpt taken from the CRXL 20-F filed Apr 14, 2005. GENE THERAPY
24 | EXCERPTS ON THIS PAGE:
|
| |||||||
